Market Snapshot

Morning Note

presented by -

Trading Observations

  • NVDA with the stick save, will it hold? That the key

  • Memory demand massive so should be a tailwind for MU + SNDK

  • WALMART SEEING LESS TARIFF IMPACT THAN EXPECTED EARLIER IN YEAR

  • Hope for the consumer https://tinyurl.com/56fn8bps [tinyurl.com]

  • 6712 the 50-day, but need a CLOSE above 6775 to give people reason to believe Santa coming to town

  • Let's hope things build as the day goes on

  • Fed on deck next (Dec 10th) and odds of cut down to 25%, I still think we get a cut so risk to upside?

  • Oscillators oversold

  • AAII Bulls subdues at 32.6% vs. 43.6% Bears

  • Non-profitable tech, wow https://tinyurl.com/2jacapbp [tinyurl.com]

Futures

DOW +487

S&P +109

Nasdaq +526

Charts/Sentiment

CNN Fear/Greed Index

U.S. 10 Year Treasury

Gold

Bitcoin

Financials / Consumer / Healthcare

EXAS – Up another 18% after reports a deal to sell to Abbott is near. Madison, WI losing a good one here to Illinois.

WMT – Up 4%. Holiday Season is off to a good start, and they are saying share take in high income consumers is real. Comps were +4.5% and Sames Club +3.8%, which compares to flat for HD. They are also headed to the Nasdaq from NYSE, which might help get it into the QQQ.

BBWI – Bath and Body Works down 17% on weak outlook and a compete strategic rethink.

Crypto Related Financials – Strong today, up 2-5%.

XYZ – Block up another 2% after a solid rip yesterday on Analyst Day. Long-term margin guidance was great.

MRNA (Covid Vaccine Maker) – Up 2% after announcing a loan from Private Credit player Ares.

Novartis raises peak sales forecasts for Kisqali to at least $10B and Scemblix to $4B – Bloomey

Vaccines/autism – the CDC has changed its website and now say vaccines may cause autism - https://www.thedailybeast.com/scientists-freak-out-as-rfk-jrs-cdc-starts-pushing-bogus-vaccine-claim/ [thedailybeast.com]

WMT - shares are up more than3% in the premarket session after the retail giant reported third-quarter results that topped Street expectations. Executives raised the annual guidance metric, resulting in what some analysts say is a “conservative” 4Q view.

Technology

Megacaps YTD scoreboard: GOOGL +55%, NVDA +39%, MSFT +16%, AAPL +7%, AMZN +2%, META +1%

Key AI related prints left on 2025 calendar: Alibaba, DELL, MDB, CRDO, MRVL, PSTG, SNOW, CRM, HPE, ADBE, CIEN, AVGO, MU

AMZN: $315 PT; Backlog Model; Paths To Mid-20%+ AWS Growth In ’26; OW Top Pick at Morgan Stanley

NVDA: +5% huge next Q rev guide of $65B (buy side $63-64B); commentary as bullish as ever / no real surprise but clearly what AI trade needed given elevated angst following wave of degrossing since late October .. "$2B of rev from Hopper chips; useful life of GPUs is being extended - positive CRWV/NBIS; Rubin progressing well / on track; no new update on China; will cont to serve OpenAI thru cloud / working on strategy partnership" ....

NVDA bankshots: long list of names up 2% - 8% .... CRWV, ALAB, NBIS, CRDO, CLS, SMIC, VRT, BE, OKLO, AMD, AAOI, COHR, LITE, ARM, PLTR, MRVL, DELL, AVGO, ANET, ORCL, WDC, STX, TSM, APH, MU, GOOGL, SNOW

Elon Musk and Nvidia CEO Jensen plan to develop a 500 megawatt data center in Saudi Arabia – Bloomey

ALAB: bullish init BNP Exane - "the stock has declined 40% from the peak on investor concerns over the market acceptance of UALink, which creates an attractive entry point; thinks Amazon's next generations of Trainium server systems could drive significant rev growth opportunities for Astera over the next three years"

DDOG: -2.4% CEO sells $18.3M of shrs

DELL: BofA positive

Industrials 

AeroVironment (AVAV) initiated overweight at Piper Sandler; $391 PT

Eaton (ETN) announces the planned transition of CFO Olivier Leonetti effective 1-Apr-26; expects no changes to its full year guidance

Hubbell (HUBB) initiated neutral at UBS; $450 PT

Parsons (PSN) upgraded to outperform from market perform at William Blair

Roper Technologies (ROP) initiated overweight at Piper Sandler; $600 PT

Topbuild (BLD) initiated sector perform at RBC Capital Markets; $410 PT

Latest Media

$PM - New and hot consumer product!

Took the stock from a 15x to 30x P/E.

Purely multiple expansion.